ShenZhen New Industries Biomedical Engineering (300832.SZ)'s major shareholder Hongshan Juye plans to reduce its shareholding by no more than 1%.
ShenZhen New Industries Biomedical Engineering (300832.SZ) announced that Hongshan Juye, a shareholder holding more than 5% of the company's shares, plans to reduce its holdings of the company's shares by no more than 1% of the company's total share capital through block trades within 3 months after 15 trading days from the date of this share reduction plan announcement.
ShenZhen New Industries Biomedical Engineering (300832.SZ) announced that Hongshan Juye, a shareholder holding more than 5% of the shares, plans to reduce its holdings of the company's shares by no more than 1% of the company's total share capital through block trades within 3 months after 15 trading days from the date of this reduction plan announcement.
Related Articles
Zhangzhou Pientzehuang Pharmaceutical (600436.SH) Chairman Lin Zhihui leaves office due to work adjustment.
Zelgen Biopharmaceutical (688266.SH): New Drug Application for Gecacitinib Hydrochloride Tablets for the Treatment of Active Ankylosing Spondylitis Accepted
Services and wealth management businesses become key "engine"! Citigroup (C.US) Q3 net profit surges 40% year-over-year, EPS beats expectations.
Zhangzhou Pientzehuang Pharmaceutical (600436.SH) Chairman Lin Zhihui leaves office due to work adjustment.
Zelgen Biopharmaceutical (688266.SH): New Drug Application for Gecacitinib Hydrochloride Tablets for the Treatment of Active Ankylosing Spondylitis Accepted
Services and wealth management businesses become key "engine"! Citigroup (C.US) Q3 net profit surges 40% year-over-year, EPS beats expectations.
